Singapore approves Cfid-19 Pfizer and BioNTech vaccine

Singapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, and is expected to receive the first photos by the end of December.

Singapore is the first Asian country to approve the vaccine, Reuters reported. Free vaccines will initially be given to health workers and the elderly.

The news agency quoted Singapore Prime Minister Lee Hsien Loong in a national program: “My colleagues and I, including the elderly, will be vaccinated early.

“This is to show you, especially the elderly like me, that we believe vaccines are safe.”

Pfizer and BioNTech also announced additional data from the phase I / II study of its BNT162b2 Covid-19 vaccine in Germany.

The data showed that the vaccine elicits a combined humoral and cellular immune response against SARS-CoV-2 and provides information on the composite nature of BNT162b2-induced T cell immunity.

BNT162b2 is authorized for emergency use in persons 16 years of age or older.

BioNTech CEO and co-founder Ugur Sahin said: “In parallel with working with regulators around the world to make our vaccine available, we will continue to share important data from our ongoing studies with the global scientific community and with the public to advance the collective understanding of the mechanism of action of the vaccine.

While there is a broad consensus that vaccines should induce antibody responses against the virus, experiences from the previous SARS pandemic indicate that CD8 + T cell responses may be critical to long-term protection.

Earlier this week, the US Food and Drug Administration (FDA) authorized the emergency use of the Pfizer and BioNTech vaccine.

In a separate development, Moderna has entered into an agreement with the Singapore Ministry of Health to deliver its candidate for Covid-19 vaccine, mRNA-1273, to provide a safe and effective vaccine.